CRISPR Therapeutics (CRSP) is soaring to new highs today. I last looked at CRSP back on October 5 and wrote that, "I am not yet convinced that CRSP can rally strongly BUT a close above $89 tells me that traders could go long risking a close below $80. Take profits around $102 if available."
More from Investing
The elevator maker's charts are pushing the right buttons.
Why we ever allowed Chinese businesses to raise capital, our capital, on our shores, is beyond me.
Conditions for 'sell the news' action is good, but is it too obvious to actually work?
The reopening stocks did well on Monday, but the underlying statistics in the market are shaky.
The Fed hopes its efforts will lead to sustainable GDP growth, but if inflation starts to run away too quickly, then Powell and company's hands could be tied.